Company Filing History:
Years Active: 2015-2017
Title: Rabi Sankar Bhatta: Innovator in Platelet Activation Inhibition
Introduction
Rabi Sankar Bhatta is an accomplished inventor based in Lucknow, India. With a strong focus on biochemical innovations, Bhatta holds a total of two patents that contribute significantly to the field of medicine, particularly in the area of platelet activation.
Latest Patents
Bhatta's most recent patents introduce novel compounds aimed at inhibiting collagen-induced platelet activation and adhesion. These patents include:
1. Chiral 1-(4-methylphenylmethyl)-5-oxo-{N-[(3-t-butoxycarbonyl-aminomethyl)]-piperidin-1-yl}-pyrrolidine
2. Chiral 1-(4-methylphenylmethyl)-5-oxo-{N-[(3-t-butoxycarbonyl-aminomethyl)]-piperidin-1-yl}-pyrrolidine-2-carboxamides.
These inventions showcase chiral (2S)-1-(4-methylphenylmethyl)-5-oxo-(3S)-{N-[(3-t-butoxycarbonyl aminomethyl)]-piperidin-1-yl}-pyrrolidine-2-carboxamide and (2S)-1-(4-methylphenylmethyl)-5-oxo-(3R)-{N-[(3-t-butoxycarbonyl aminomethyl)]-piperidin-1-yl}-pyrrolidine-2-carboxamide. The inventions utilize a unique process to prepare these chiral carboxamides, effectively avoiding racemization during N-alkylation, using the reagent LiHMDS at low temperatures.
Career Highlights
Rabi Sankar Bhatta has made notable advancements in the biomedical field through his innovative research at the Council of Scientific and Industrial Research. His work has played a crucial role in developing inhibitors that mediate the effects of collagen receptors on platelet aggregation and adhesion, which may have important therapeutic implications.
Collaborations
Throughout his career, Bhatta has collaborated with esteemed colleagues such as Dinesh Kumar Dikshit and Madhu Dikshit. These collaborations have fostered an environment of shared knowledge and innovation, further enhancing the efficacy of their research contributions.
Conclusion
Rabi Sankar Bhatta exemplifies the spirit of innovation within the scientific community. His contributions through his patents not only demonstrate his expertise but also his commitment to advancing medical science. As he continues to work at the Council of Scientific and Industrial Research, the impact of his inventions may pave the way for critical developments in platelets' role in cardiovascular health.